Chemoinformaics analysis of Hydroxyprogesterone
| Molecular Weight | 330.468 | nRot | 1 |
| Heavy Atom Molecular Weight | 300.228 | nRig | 22 |
| Exact Molecular Weight | 330.219 | nRing | 4 |
| Solubility: LogS | -4.334 | nHRing | 0 |
| Solubility: LogP | 3.325 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 57.4798 |
| nHD | 1 | BPOL | 31.8322 |
| QED | 0.743 |
| Synth | 4.227 |
| Natural Product Likeliness | 2.241 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.819 |
| Pgp-sub | 0.005 |
| HIA | 0.008 |
| CACO-2 | -4.723 |
| MDCK | 0.0000168 |
| BBB | 0.954 |
| PPB | 0.835429 |
| VDSS | 0.784 |
| FU | 0.0633728 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.799 |
| CYP2c19-inh | 0.2 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.064 |
| CYP2c9-sub | 0.134 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.122 |
| CYP3a4-inh | 0.455 |
| CYP3a4-sub | 0.911 |
| CL | 6.421 |
| T12 | 0.842 |
| hERG | 0.052 |
| Ames | 0.014 |
| ROA | 0.042 |
| SkinSen | 0.871 |
| Carcinogencity | 0.848 |
| EI | 0.227 |
| Respiratory | 0.937 |
| NR-Aromatase | 0.843 |
| Antiviral | No |
| Prediction | 0.670845 |